HealthEquity, Inc.

HQY Healthcare Health Information Services

HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

92.03 0.48 −0.52%
Market cap
$7.7B
P/E
33.0×
Fwd P/E
30.2×
Dividend yield
—
F-score
9/9
Altman Z
4.39
Beneish M
−2.77
Dividend safety
n/a
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
ROE
11.43% 11.06% 10.19% 9.01%

+8 more TTM periods

Piotroski F-Score
8 8 9 9
ROA
7.07% 6.86% 6.30% 5.57%
ROIC
8.24% 7.85% 7.34% 6.54%
Return on Tangible Assets
75.98% 68.95% 60.01% 50.29%
Average Days of Receivables
32.74 33.30 34.37 31.46
Free Cash Flow per Share
5.24 5.23 4.74 4.22
Free Cash Flow
436.95 441.25 408.32 362.67
Capital Expenditures
(53.22) (48.63) (48.78) (52.26)
Other line items
Cash ROIC
13.75% 13.55% 12.07% 10.59%
Accounts Receivable Turnover
11.67 11.23 10.87 11.84
Accounts Payable Turnover
43.06 28.30 30.19 27.87
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
8.01 13.24 11.09 17.13
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.23) (0.23) (0.22) (0.22)
Research and Development Expense of Revenue
20.41% 20.10% 19.99% 19.90%
Selling, General and Administrative Expense of Revenue
16.87% 16.57% 16.38% 16.25%
Share Based Compensation of Revenue
5.97% 5.84% 5.56% 5.86%
Interest Coverage
6.69 6.24 5.64 4.97
Operating CF/Net income
2.07 2.12 2.12 2.16
Depreciation/Fixed assets
32.87 40.79 49.01 46.08
Capex/Depreciation
(0.34) (0.31) (0.31) (0.33)
Revenue per Share
16.34 15.84 15.25 15.01
Operating CF per Share
5.88 5.80 5.31 4.83
Capex per Share
(0.64) (0.58) (0.57) (0.61)
Capex to Sales
0.04 0.04 0.04 0.04

Fold the line items

Columns are period end dates